GlobeNewswire Inc | Oct 14, 2020 05:21PM EDT

October 14, 2020

CARLSBAD, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close onWednesday, October 28, 2020. Management will hold a conference call to review the company's financial performance starting at1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day. The conference call will be concurrently webcast.

The link to the webcast will be available on theGenMark Diagnostics, Inc.website atwww.genmarkdx.comunder the investor relations section and will be archived for future reference. To listen to the conference call, please dial (877) 312-5847 (US/Canada) or (253) 237-1154 (International) and use the conference ID number 2955234 approximately ten minutes prior to the start time.

ABOUTGENMARK DIAGNOSTICSGenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor detection technology, GenMark's eSensor XT-8 and ePlex systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMarks ePlex: The True Sample-to-Answer Solution is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.

Investor Relations ContactLeigh Salvo(415) 937-5404ir@genmarkdx.com